Home Owner Programs
The purpose of this funding opportunity announcement (FOA) is to repurpose already FDA approved drugs for new neonatal and obstetric indications, in order to overcome the difficulties associated with the traditional development of drugs appropriate for use in neonates and pregnant women and facilitate
treatment of these vulnerable populations.
Obtain Full Opportunity Text:
http://grants.nih.gov/grants/guide/pa-files/PAR-18-506.htmlAdditional Information of Eligibility:
Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are not eligible to apply.
Non-domestic (non-U.S.) components of U. S. Organizations are not eligible to apply.
Foreign components, as defined in the NIH Grants Policy Statement, are allowed.Full Opportunity Web Address:http://grants.nih.gov/grants/guide/pa-files/PAR-18-506.htmlContact: Agency Email Description:
If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster Agency Email: Date Posted:
2017-12-18Application Due Date: Archive Date:
Jim Fruchterman founded the now 24-year-old social enterprise Benetech, a nonprofit tech company that focuses on developing technology for...